Cannabis-based therapeutic product for treatment of chronic pain
A cannabis based therapeutic product for treatment of chronic pain produced by separating hash resin from plant material of the cannabis plant, pressing the hash resin to expel oil, leaving spent hash resin, extracting further cannabinoids from the spent hash resin using MCT oil, separating the cannabis compounds from the oils using high pressure liquid chromatography, flash chromatography, or similar techniques, and processing selected cannabis compound formulations into a pill, tablet, liquid, or other form suitable for administration as a therapeutic product for treatment of chronic pain, optionally with the further step of enriching the product with a formulation comprising at least 1% by weight purified -myrcene, prior to processing into a final product.
1. A method of preparing a cannabis -based therapeutic product for the treatment of chronic pain, the method comprising the steps of:
(a) separating hash resin from plant material of a cannabis plant of a specific strain;
(b) pressing the hash resin to expel oil, leaving spent hash resin;
(c) extracting further cannabinoids from the spent hash resin using MCT oil;
(d) separating the cannabis compounds from the oils using high pressure liquid chromatography or flash chromatography;
(e) mixing cannabis compounds obtained via steps (a)-(d) from one or more strains of cannabis to obtain a formulation therapeutically-effective for use in treating chronic pain; and
(f) processing the formulation from step (e) into a pill or tablet suitable for therapeutic administration to a human patient;
wherein the formulation comprises at least 5% w/w β-myrcene, between 20% w/w and 35% w/w cannabidiol, at least 10% α-pinene, at least 5% w/w terpineol, and at least 10% w/w borneol.
2. The method of claim 1 , wherein the formulation further comprises at least 5% w/w p-cymene.
3. A cannabis -based treatment product for chronic pain produced according to the method of claim 1 .
4. A cannabis -based treatment product for chronic pain produced according to the method of claim 2 .